Basic Information
Halucenex is a life sciences development company focused on researching novel psychedelic compounds, developing and licensing these compounds for the pharmaceutical and nutraceutical markets, and conducting clinical trials on the medical benefits of psychedelic drugs. Halucenex operates a 6,000-square-foot medical facility in Windsor, Nova Scotia, with six therapy rooms and a secure laboratory dedicated to psychedelic-assisted psychotherapy and clinical research. Halucenex intends to maintain control over all aspects of the product development process: mycology research, extraction techniques and synthetic formulations, drug delivery technologies, psychedelic-assisted psychotherapy, and regulatory affairs.